SCHEMBL24878744

SCHEMBL24878744

Cc1c(C(F)F)cccc1N1CCN(C(=O)Cn2nc(C(=O)N3CC[C@H](O)[C@H](F)C3)c3c2C[C@H]2CC32)CC1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.85
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 4/20 0.34
ALOX15 P16050 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TP53 P04637 3/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CXCR3 P49682 1/20 0.32
KCNH2 Q12809 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
CCR1 P32246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24878370 1.00 IDO1 (0.85) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL30129108 1.00 IDO1 (0.85) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL30128921 1.00 IDO1 (0.85) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878179 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878698 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878037 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878217 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878184 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878730 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15
SCHEMBL24878725 0.92 IDO1 (1.00) IDO1NPC1RAB9AMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230008022-A1 NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230008022-A1 NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS IDO1, IDO2, KYNU IDO1 1/4885NPC1 1917/4885RAB9A 2933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.